Emerging treatments for neuromyelitis optica spectrum disorder

被引：2
|
作者：
Wynford-Thomas, Ray [1 ]
Robertson, Neil P. [1 ]
机构：
[1] Cardiff Univ, Univ Hosp Wales, Inst Psychol Med & Clin Neurosci, Heath Pk, Cardiff CF14 4XN, Wales
来源：
JOURNAL OF NEUROLOGY | 2020年 / 267卷 / 09期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1007/s00415-020-10083-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2771 / 2773
页数：3
相关论文
共 50 条
  • [21] What Is the Optimal Sequence of Rescue Treatments for Attacks of Neuromyelitis Optica Spectrum Disorder?
    Weinshenker, Brian G.
    ANNALS OF NEUROLOGY, 2016, 79 (02) : 204 - 205
  • [22] Preferences for neuromyelitis optica spectrum disorder treatments: A conjoint analysis with neurologists in Spain
    Tellez-Lara, Nieves
    Gomez-Ballesteros, Rocio
    Sepulveda, Maria
    Orviz, Aida
    Diaz-Sanchez, Maria
    Boyero, Sabas
    Aguado-Valcarcel, Marta
    Cobo-Calvo, Alvaro
    Lopez-Laiz, Paloma
    Rebollo, Pablo
    Maurino, Jorge
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 88
  • [23] Neuromyelitis Optica Spectrum Disorder (NMOSD): Epidemiology, Treatments, and Outcomes in a Single Center
    Kadish, Robert
    Parker, Tavan
    Tanvir, Imran
    Royston, Minying
    Kielhorn, Adrian
    Biskupiak, Joseph
    Clardy, Stacey
    NEUROLOGY, 2020, 94 (15)
  • [24] Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder
    Fujita-Nakata, M.
    Tomioka, R.
    Tanaka, K.
    Nakanishi, M.
    Nagayama, S.
    Takahashi, R.
    Machiya, T.
    Hamada, T.
    Matsui, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 576 - 577
  • [25] Patients with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder: Turkish Multicenter Data
    Altintas, A.
    Karabudak, R.
    Balci, B. Petek
    Terzi, M.
    Soysal, A.
    Saip, S.
    Kurne, A. Tuncer
    Uygunoglu, U.
    Nalbantoglu, M.
    Gozubatik-Celik, G.
    Isik, N.
    Celik, Y.
    Gokcay, F.
    Duman, T.
    Boz, C.
    Yucesan, C.
    Celebisoy, N.
    Diker, S.
    Isikay, I. C.
    Kansu, T.
    Siva, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 824 - 825
  • [26] Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
    Collongues, N.
    Marignier, R.
    Jacob, A.
    Leite, M. I.
    Sivas, A.
    Paul, F.
    Zephir, H.
    Akman-Demirs, G.
    Elsone, L.
    Jarius, S.
    Papeix, C.
    Mutch, K.
    Saips, S.
    Wildemann, B.
    Kitley, J.
    Karabudak, R.
    Aktas, O.
    Kuscu, D.
    Altintas, A.
    Palace, J.
    Confavreux, C.
    De Seze, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (08) : 1086 - 1094
  • [27] An emerging etiology of spinal cord injury resembling neuromyelitis optica spectrum disorder
    Girame-Rizzo, Lidia
    de Gordoa, Estibaliz Saez
    Vilaseca, Andreu
    Auger, Cristina
    Montalban, Xavier
    NEUROLOGICAL SCIENCES, 2024, 45 (08) : 4063 - 4066
  • [28] Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Fung, Simon
    Shirley, Matt
    CNS DRUGS, 2023, 37 (04) : 363 - 370
  • [29] Inebilizumab for treatment of neuromyelitis optica spectrum disorder
    Tullman, Mark J.
    Zabeti, Aram
    Vuocolo, Scott
    Dinh, Quinn
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (05) : 341 - 352
  • [30] Satralizumab in the treatment of neuromyelitis optica spectrum disorder
    Duchow, Ankelien
    Bellmann-Strobl, Judith
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 49 - 59
12345